B cell boost for hay fever therapy

L-R: Authors Dr Craig McKenzie, Prof Robyn O'Hehir and
Prof Menno van Zelm. See paper for full list of authors.

Grass pollen allergy is the leading cause of seasonal asthma and hay fever globally with up to 30 per cent of the world’s population allergic to grass pollen allergens.

In a discovery that may help scientists alleviate this global burden, Monash researchers have found that sublingual immunotherapy (SLIT) with a small tablet containing grass pollens, changed patient’s immune memory cells in unexpected ways.

See full faculty story.